Skip to main content
Clinical Trials/NCT02876458
NCT02876458
Completed
Not Applicable

EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest With no Obvious Non Cardiac Cause of Arrest

Assistance Publique - Hôpitaux de Paris1 site in 1 country336 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Out-of-Hospital Cardiac Arrest
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
336
Locations
1
Primary Endpoint
Survival with no or minimal neurological sequel
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Sudden cardiac death (SCD) remains a major public health issue with a low survival rate. The most common cause of SCD is acute coronary artery occlusion. Several registry based studies suggest that coronary angiography (CA) performed at admission followed if necessary by coronary angioplasty improves in-hospital and long term survival. Recent guidelines recommend performing an immediate CA in all survivors of SCD with no obvious non cardiac cause of arrest. However there is a lack of randomized data on this topic.

Several retrospective studies have shown that if the post-resuscitation electrocardiogram (ECG) shows ST segment elevation, the probability of finding an acute coronary artery lesion during the CA is high (70-80%). In contrast, if no ST segment elevation is present the probability is low (15-20%).

Performing an immediate CA in all survivors of SCD can be challenging. It requires admitting these patients to centers with an intensive care unit and facilities allowing 24/24 7/7 CA. It may increase the delay of performing other therapeutic modalities such as CT brain or thorax scan to determine the cause of SCD. Performing the CA 48 to 96 hours after admission would facilitate the management of these difficult patients. However if the cause of the arrest is a coronary artery occlusion and there is a delay in reperfusion, the rate of post-arrest shock and the mortality may increase. Therefore a randomized study comparing immediate versus delayed (between 48 to 96 hours) CA in survivors of SCD with no obvious non-cardiac cause of arrest is warranted.

Detailed Description

The design consists in a multicenter national randomized open parallel group trial. All eligible patients with SCD will be included and randomized by the Emergency Medical Service (EMS) to one of the 2 following arms: immediate CA vs delayed CA. Patients randomized in the immediate CA group will be admitted directly to the catheterization laboratory. Patients randomized in the delayed CA will be admitted to the intensive care unit and a CA will be planned 48 to 96 hours after admission. Investigators can perform the CA in the delayed group \< 48 hours if the following events appear: * ST segment elevation or new left bundle branch block on the ECG * Shock unresponsive to inotropes * "Electrical storm" (repeated Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF)) * Segmental hypokinesia or akinesia on an echocardiogram Echocardiography and assessment of neurological status are done at discharge form the Intensive Care Unit, at hospital discharge and during the follow-up visits (90 and 180 days).

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
November 23, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Out-of-hospital SCD with return of spontaneous circulation
  • Age ≥ 18 years of age
  • No obvious non-cardiac cause of arrest
  • Admitted to a center with an intensive care unit and a 24 hours a day, 7 days a week interventional cardiology department
  • Affiliation to the French Social Security Health Care plan

Exclusion Criteria

  • Age \< 18 years of age
  • In-hospital SCD
  • No return of spontaneous circulation
  • Presence of ST segment elevation
  • Suspected non-cardiac aetiology (trauma, respiratory, neurological, etc.)
  • Presence of co-morbidities with life expectancy of less than a year
  • Pregnancy
  • Adults subject to a legal protection measure (guardianship or tutelage measure)
  • Participation in another interventional trial

Outcomes

Primary Outcomes

Survival with no or minimal neurological sequel

Time Frame: 180 days

Survival rate with no or minimal neurological sequel (CPC (cerebral performance category) 1 or 2) at 6 months after inclusion

Secondary Outcomes

  • CPC score(180 days)
  • Overall survival rate(180 days)
  • Arrhythmia(48 hours)
  • Shock(48 hours)
  • Glasgow Outcome Scale Extended score (GOSE)(180 days)
  • The evolution of left ventricular ejection fraction evolution(180 days)
  • Hospital stay length(180 days)

Study Sites (1)

Loading locations...

Similar Trials